https://www.selleckchem.com/pr....oducts/rimiducid-ap1
It is important to develop targeted prevention and treatment strategies against these risk factors to reduce the occurrence of VTE in patients with gynecological malignancy during the perioperative period. It is important to develop targeted prevention and treatment strategies against these risk factors to reduce the occurrence of VTE in patients with gynecological malignancy during the perioperative period. Critically ill COVID-19 patients have a clear pattern of inflammation and hypercoagulable state. The main aim of the stud
Like
Comment
Share
